| Analysis | Metabolite Name | Measured Value | Units | Group | Timepoint | Gender | Age at start of study (years) |
|---|---|---|---|---|---|---|---|
| GC POSITIVE ION MODE | pelargonic acid | 1353 | Counts | Synbiotic | Baseline (days 5-7) | Male castrated | 7 |
| GC POSITIVE ION MODE | pelargonic acid | 2308 | Counts | Placebo | Baseline (days 5-7) | Male castrated | 7 |
| GC POSITIVE ION MODE | pelargonic acid | 5612 | Counts | Synbiotic | Baseline (days 5-7) | Female spayed | 10 |
| GC POSITIVE ION MODE | pelargonic acid | 6353 | Counts | Placebo | Baseline (days 5-7) | Female spayed | 10 |
| GC POSITIVE ION MODE | pelargonic acid | 7043 | Counts | Placebo | Baseline (days 5-7) | Male castrated | 9 |
| GC POSITIVE ION MODE | pelargonic acid | 7795 | Counts | Synbiotic | Baseline (days 5-7) | Male castrated | 9 |
| GC POSITIVE ION MODE | pelargonic acid | 8360 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | pelargonic acid | 8498 | Counts | Synbiotic | Completion of treatment (days 26-28) | Male castrated | 9 |
| GC POSITIVE ION MODE | pelargonic acid | 8502 | Counts | Synbiotic | Recovery (days 68-70) | Male castrated | 9 |
| GC POSITIVE ION MODE | pelargonic acid | 8549 | Counts | Placebo | Baseline (days 5-7) | Female spayed | 10 |
| GC POSITIVE ION MODE | pelargonic acid | 8820 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | pelargonic acid | 8873 | Counts | Synbiotic | Completion of treatment (days 26-28) | Male castrated | 9 |
| GC POSITIVE ION MODE | pelargonic acid | 8913 | Counts | Synbiotic | Baseline (days 5-7) | Male castrated | 9 |
| GC POSITIVE ION MODE | pelargonic acid | 8986 | Counts | Placebo | Recovery (days 68-70) | Female spayed | 10 |
| GC POSITIVE ION MODE | pelargonic acid | 9981 | Counts | Synbiotic | Baseline (days 5-7) | Male castrated | 9 |
| GC POSITIVE ION MODE | pelargonic acid | 10058 | Counts | Placebo | Recovery (days 68-70) | Female spayed | 10 |
| GC POSITIVE ION MODE | pelargonic acid | 10130 | Counts | Placebo | Recovery (days 68-70) | Male castrated | 9 |
| GC POSITIVE ION MODE | pelargonic acid | 10366 | Counts | Synbiotic | Recovery (days 68-70) | Male castrated | 9 |
| GC POSITIVE ION MODE | pelargonic acid | 10730 | Counts | Synbiotic | Baseline (days 5-7) | Male castrated | 9 |
| GC POSITIVE ION MODE | pelargonic acid | 10761 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | pelargonic acid | 10805 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | pelargonic acid | 10835 | Counts | Synbiotic | Recovery (days 68-70) | Female spayed | 10 |
| GC POSITIVE ION MODE | pelargonic acid | 11064 | Counts | Placebo | Baseline (days 5-7) | Female spayed | 5 |
| GC POSITIVE ION MODE | pelargonic acid | 11094 | Counts | Placebo | Recovery (days 68-70) | Female spayed | 7 |
| GC POSITIVE ION MODE | pelargonic acid | 11172 | Counts | Placebo | Completion of treatment (days 26-28) | Male castrated | 7 |
| GC POSITIVE ION MODE | pelargonic acid | 11258 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | pelargonic acid | 11656 | Counts | Synbiotic | Baseline (days 5-7) | Female spayed | 5 |
| GC POSITIVE ION MODE | pelargonic acid | 11820 | Counts | Synbiotic | Completion of treatment (days 26-28) | Female spayed | 5 |
| GC POSITIVE ION MODE | pelargonic acid | 11836 | Counts | Synbiotic | Recovery (days 68-70) | Male castrated | 9 |
| GC POSITIVE ION MODE | pelargonic acid | 11997 | Counts | Placebo | Completion of treatment (days 26-28) | Male castrated | 7 |
| GC POSITIVE ION MODE | pelargonic acid | 12029 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | pelargonic acid | 12899 | Counts | Placebo | Recovery (days 68-70) | Female spayed | 5 |
| GC POSITIVE ION MODE | pelargonic acid | 12988 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | pelargonic acid | 13480 | Counts | Synbiotic | Baseline (days 5-7) | Male castrated | 9 |
| GC POSITIVE ION MODE | pelargonic acid | 13587 | Counts | Placebo | Baseline (days 5-7) | Female spayed | 5 |
| GC POSITIVE ION MODE | pelargonic acid | 14442 | Counts | Placebo | Recovery (days 68-70) | Male castrated | 7 |
| GC POSITIVE ION MODE | pelargonic acid | 14668 | Counts | Synbiotic | Recovery (days 68-70) | Male castrated | 9 |
| GC POSITIVE ION MODE | pelargonic acid | 15241 | Counts | Synbiotic | Recovery (days 68-70) | Male castrated | 7 |
| GC POSITIVE ION MODE | pelargonic acid | 15404 | Counts | Placebo | Completion of treatment (days 26-28) | Male castrated | 9 |
| GC POSITIVE ION MODE | pelargonic acid | 15795 | Counts | Synbiotic | Recovery (days 68-70) | Male castrated | 9 |
| GC POSITIVE ION MODE | pelargonic acid | 15928 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | pelargonic acid | 15997 | Counts | Synbiotic | Completion of treatment (days 26-28) | Male castrated | 9 |
| GC POSITIVE ION MODE | pelargonic acid | 16234 | Counts | Placebo | Baseline (days 5-7) | Male castrated | 7 |
| GC POSITIVE ION MODE | pelargonic acid | 16240 | Counts | Placebo | Completion of treatment (days 26-28) | Female spayed | 5 |
| GC POSITIVE ION MODE | pelargonic acid | 16302 | Counts | Synbiotic | Completion of treatment (days 26-28) | Male castrated | 7 |
| GC POSITIVE ION MODE | pelargonic acid | 16881 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | pelargonic acid | 18196 | Counts | Placebo | Recovery (days 68-70) | Female spayed | 5 |
| GC POSITIVE ION MODE | pelargonic acid | 18367 | Counts | Placebo | Baseline (days 5-7) | Female spayed | 7 |
| GC POSITIVE ION MODE | pelargonic acid | 18786 | Counts | Placebo | Recovery (days 68-70) | Male castrated | 7 |
| GC POSITIVE ION MODE | pelargonic acid | 19580 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | pelargonic acid | 23282 | Counts | Synbiotic | Recovery (days 68-70) | Female spayed | 5 |
| GC POSITIVE ION MODE | pelargonic acid | 31251 | Counts | Synbiotic | Completion of treatment (days 26-28) | Female spayed | 10 |
| GC POSITIVE ION MODE | pelargonic acid | 33388 | Counts | Synbiotic | Completion of treatment (days 26-28) | Male castrated | 9 |
| GC POSITIVE ION MODE | pelargonic acid | 44059 | Counts | NA | NA | NA | - |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|